Volume 1, Issue 6, Pages 1-2 (June 2006)
4 of 44
PREVIEW
FULL TEXT
FULL-TEXT PDF (284 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The future of dual α-/γ-peroxisome proliferator-activated receptor agonists may now be in question since development has been halted on two agents after completion of phase III trials.
PII: S1558-0164(06)70178-X
doi:10.1016/S1558-0164(06)70178-X
© 2006 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.